Pharma News

Apitegromab remains on track to be the first and only muscle-targeted treatment for people living with Spinal Muscular Atrophy

Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development, manufacture and commercialisation of the former’s ESK-001 for dermatological indications in Ja...

Alnylam’s Amvuttra granted FDA approval for rare heart disease ATTR-CM

AstraZeneca has announced a $2.5bn investment in the company’s sixth worldwide strategic research and development (R&D) centre in Beijing, China.

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference ...

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years. Johnson & Johnson Innovative Medicine (J&J) is significantly expanding ...

China’s National Medical Products Administration (NMPA) has granted conditional approval for Hutchmed’s Tazverik (tazemetostat) to treat adults with relapsed or refractory (R/R...

Sanofi is continuing its immunology pipeline push with an agreement to acquire Dren Bio’s bispecific antibody  n a deal whose value could rise to $1.9bn. Sanofi’s move for Dren Bio’s c...

Johnson & Johnson (J&J) has received US Food and Drug Administration (FDA) approval for its interleukin 23 inhibitor, Tremfya (guselkumab), to treat moderately to severely acti...

Poxel Announces Positive Results from a Preclinical Study for PXL065, a Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone, in Hypertrophic Cardiomyopathy

KNOXVILLE, Tenn. (WVLT) - At the Metro Drug Coalition in Knoxville, they see addiction walk through the door every day.

Sona Nanotech Inc. has released new preclinical data demonstrating the efficacy of its Targeted Hyperthermia Therapy (THT) in inhibiting tumor growth in an immunotherapy-resistant colorectal c...